We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

57 hedge funds and large institutions have $132M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

36% more funds holding

Funds holding: 4257 (+15)

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

18% more capital invested

Capital invested by funds: $112M → $132M (+$19.8M)

2.98% more ownership

Funds ownership: 25.82%28.8% (+3%)

23% less call options, than puts

Call options by funds: $277K | Put options by funds: $359K

Holders
57
Holders Change
+15
Holders Change %
+35.71%
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
21
Increased
16
Reduced
12
Closed
5
Calls
$277K
Puts
$359K
Net Calls
-$82K
Net Calls Change
-$154K
Name Holding Trade Value Shares
Change
Change in
Stake
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$33.6M +$1.97M +445,264 +6%
HA
2
HHLR Advisors
Cayman Islands
$23.8M
Morgan Stanley
3
Morgan Stanley
New York
$15.1M +$6.87M +1,553,462 +70%
SL
4
Siren LLC
Connecticut
$11.9M +$8.12M +1,834,043 +157%
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$9.15M +$9.83M +2,221,153 +2,872%
ACM
6
Ariose Capital Management
Hong Kong
$5.43M -$1.51M -340,878 -20%
CS
7
Candriam SCA
Luxembourg
$4.51M
WP
8
Woodline Partners
California
$4.18M
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$3.98M -$10.3M -2,338,034 -70%
Millennium Management
10
Millennium Management
New York
$3.37M +$3.64M +823,555 +3,668%
Barclays
11
Barclays
United Kingdom
$2.5M +$1.03M +233,492 +59%
BlackRock
12
BlackRock
New York
$2.46M +$2.74M +618,347 New
EAM
13
Exome Asset Management
New York
$1.99M -$4.16M -940,017 -65%
ACM
14
AIHC Capital Management
$1.65M +$1.83M +413,979 New
State Street
15
State Street
Massachusetts
$1.43M +$99.5K +22,478 +7%
Connor, Clark & Lunn Investment Management (CC&L)
16
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$763K +$122K +27,650 +17%
UBS Group
17
UBS Group
Switzerland
$723K -$501K -113,302 -38%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$591K +$220K +49,676 +50%
Goldman Sachs
19
Goldman Sachs
New York
$561K -$343K -77,524 -35%
XT
20
XTX Topco
Cayman Islands
$561K +$304K +68,763 +95%
JP Morgan Chase
21
JP Morgan Chase
New York
$525K -$81.1K -18,334 -12%
TAMH
22
Taikang Asset Management (HK)
Hong Kong
$512K +$570K +128,765 New
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$464K -$12.4K -2,807 -2%
AA
24
ALPS Advisors
Colorado
$448K +$4.25K +961 +0.9%
DACS
25
Dymon Asia Capital (Singapore)
Singapore
$320K +$356K +80,400 New

NBP Hedge Fund Activity: Q4 2025 in Review

57 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2025, worth a combined $132M — up 18% from $112M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NBP positions and 5 closed out — a net gain of 16 holders — while 16 added to existing stakes and 12 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $9.83M. The largest seller was Adage Capital Partners, cutting an estimated $10.3M.

  • 57 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2025, up from 42 in Q3 2025.
  • Funds reported $132M of NovaBridge Biosciences American Depositary Shares stock for Q4 2025, up 18% quarter-over-quarter.
  • 21 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2025 and 5 closed out, a net change of +16 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2025 was Point72 Asset Management, an estimated $9.83M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2025 was Adage Capital Partners, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2025.